https://www.live-feeds.com/feed/astrazeneca-ceo-strikes-bullish-tone-on-pipeline-as-stock-ralliesContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/astrazeneca-ceo-strikes-bullish-tone-on-pipeline-as-stock-rallieshttps://www.live-feeds.com/feed/astrazeneca-ceo-strikes-bullish-tone-on-pipeline-as-stock-rallies#u177724Thu, 05 Nov 2026 15:25:16 +0000AstraZeneca shares jumped nearly 7%, marking the largest one-day rally in a year, after the company beat Q3 forecasts with $16.21 billion in revenue and a 23% jump in profit driven by cancer drugs. CEO Pascal Soriot announced a plan to save approximately $1.5 billion annually to fund the drug pipeline and meet 2030 targets. While the company claims the workforce will not shrink, the reorganization may involve R&D cuts and shifting clinical trials to emerging markets. Three brokers raised their price targets following the results.Why it mattersThe company is shifting its focus toward long-t